By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sunshine Biopharma, Inc. 

6100 Royalmount Avenue

Montreal  Quebec  H4P 2R2  Canada
Phone: 514-496-5197 Fax: 450-689-639



Company News
Sunshine Biopharma, Inc. Negotiating With CRO's To Initiate Master Drug File For Adva-27a Anticancer Compound 9/4/2014 1:08:34 PM
Sunshine Biopharma, Inc. Launches Sunshine Biopharma Canada Inc., A Wholly Owned Canadian Subsidiary In Anticipation Of Signing Manufacturing And Commercialization Contracts In Canada 7/29/2014 11:40:17 AM
Sunshine Biopharma, Inc.'s Adva-27a Featured In 2014 Worldwide Uterine Cancer Report For Its Effectiveness Against Multidrug Resistant Uterine Cancer Cells 6/10/2014 10:22:28 AM
Sunshine Biopharma, Inc. Announces Issuance Of Notice Of Allowance For The Patent Application Covering Adva-27a Anticancer Compound In Canada 5/12/2014 10:17:01 AM
Sunshine Biopharma, Inc. Secures Funding For Its Adva-27a Anticancer Compound From Dutchess Opportunity Fund II 4/29/2014 11:10:19 AM
Sunshine Biopharma, Inc. Increases The Effectiveness Of Adva-27a Lead Compound 9.5-Fold Against Breast And Pancreatic Cancer In Vitro 4/8/2014 10:31:00 AM
Management Of Sunshine Biopharma, Inc. Alarmed By The Recent World Health Organization Report That Cancer Is On The Rise 4/1/2014 9:36:35 AM
Sunshine Biopharma, Inc. Begins Construction Of Mouse Xenograft Models For Pancreatic Cancer To Advance Adva-27a As A Treatment For This Deadly Form Of Cancer 2/17/2014 10:33:47 AM
Sunshine Biopharma, Inc. Continues Its Efforts To Re-Domicile In Canada For Business Expansion And Financing Opportunities For Adva-27a Cancer Drug Candidate 2/5/2014 9:44:28 AM
Sunshine Biopharma, Inc. Targets Pancreatic Cancer As Second Indication For Clinical Trials Of Adva-27a Compound 1/21/2014 10:08:08 AM